John Wallen, JD, PhD (Intellectual Property Advisor) advises the company on intellectual property matters. With over 30 years of experience in the pharmaceutical business, John specializes in creating and executing the IP strategy for emerging biotech companies.
He is currently General Counsel at Avidity Biosciences. Previously, he held the position of Vice President, Intellectual Property & Corporate Legal at Ambrx, Inc. He worked for Merck, serving first as a scientist and then as a USPTO registered patent attorney. John served as a patent attorney in the law department of Johnson & Johnson, and then was a partner in the Technology/Intellectual Property, Life Sciences, and Patent Litigation groups of the law firm Preston Gates & Ellis LLP. John earned a BS in Biology from State University of New York College at Oswego, MS in Clinical Microbiology from Long Island University, PhD in Molecular Biology from University of Pennsylvania, and JD from Seton Hall Law School.